Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab cataract risk study in men with non-metastatic prostate cancer on androgen-deprivation therapy
2009-012076-26Phase 3Completed
- Sponsor
- Amgen
- Start
- Aug 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in osteoporosis and prostate cancer (PCa) comparing Denosumab with Placebo (2 arms). Started Aug 2009; status: completed.
02
Drugs
denosumab
03
Conditions
osteoporosisprostate cancer (PCa)
Beyond the preview
Go deeper on 2009-012076-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012076-26.